FDA Inspection 1300034 — South Florida Institute For Reproductive Medicine, P.A.
The FDA completed an inspection of South Florida Institute For Reproductive Medicine, P.A. on January 22, 2026 in South Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 22, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- South Miami, FL (United States)